Arcturus Therapeutics Holdings (ARCT) Non Operating Income (2018 - 2026)

Arcturus Therapeutics Holdings has reported Non Operating Income for 9 years, with the latest figure at $35000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income rose 266.67% year-over-year to $35000.0; the trailing twelve-month figure through Mar 2026 stood at $7.4 million (down 34.05% YoY), and the FY2025 full-year result was $10.1 million, down 33.56% from the prior year.
• Non Operating Income for Q1 2026 stood at $35000.0, down from $1.5 million in the prior quarter.
• The five-year high for Non Operating Income was $6.9 million in Q4 2023, with the low at -$564000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $2.3 million across 5 years, with a median of $2.6 million in 2025.
• Annual changes were most pronounced in 2023 — Non Operating Income surged 1340.19% — and 2025, when it slumped 100.52%.
• Arcturus Therapeutics Holdings' Non Operating Income stood at $1.0 million in 2022, then surged by 571.32% to $6.9 million in 2023, then slumped by 53.29% to $3.2 million in 2024, then sank by 52.61% to $1.5 million in 2025, then slumped by 97.7% to $35000.0 in 2026.
• The last three Non Operating Income figures came in at $35000.0 (Q1 2026), $1.5 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.